Skip to main content
Top
Published in: International Cancer Conference Journal 4/2018

01-10-2018 | Case report

A young female case of primary renal carcinoid tumor mimicking fat-poor angiomyolipoma

Authors: Rie Kato, Hiroshi Fukushima, Masaki Kobayashi, Keizo Kawano, Shinji Morimoto

Published in: International Cancer Conference Journal | Issue 4/2018

Login to get access

Abstract

Renal mass biopsy is useful for the pathological diagnosis of a small renal mass difficult to distinguish fat-poor angiomyolipoma from renal cell carcinoma radiologically. Here, we report a young female case of a small renal mass suspected as fat-poor angiomyolipoma in imaging studies. The patient received a renal mass biopsy to obtain the correct pathological information. Unexpectedly, the pathological diagnosis was neuroendocrine tumor. She, finally, underwent a right radical nephrectomy as a curative treatment. This case indicates that the radiological findings of primary renal carcinoid tumor can be similar to those of fat-poor angiomyolipoma.
Literature
1.
go back to reference Iimura Y, Kihara K, Saito K et al (2008) Oncological outcom of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma. Int J Urol 15:44–47CrossRefPubMed Iimura Y, Kihara K, Saito K et al (2008) Oncological outcom of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma. Int J Urol 15:44–47CrossRefPubMed
2.
go back to reference Fujii Y, Komai Y, Saito K et al (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 72:598–602CrossRefPubMed Fujii Y, Komai Y, Saito K et al (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 72:598–602CrossRefPubMed
3.
go back to reference Jinzaki M, Silverman SG, Akita H et al (2014) Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 39:588–604CrossRefPubMedPubMedCentral Jinzaki M, Silverman SG, Akita H et al (2014) Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 39:588–604CrossRefPubMedPubMedCentral
4.
go back to reference Schieda N, Hodgdon T, El-Khodary M et al (2014) Unenhanced CT for the diagnosis of minimal-fat renal angiomyolipoma. Am J Roentgenol 203:1236–1241CrossRef Schieda N, Hodgdon T, El-Khodary M et al (2014) Unenhanced CT for the diagnosis of minimal-fat renal angiomyolipoma. Am J Roentgenol 203:1236–1241CrossRef
5.
go back to reference Tanaka H, Fujii Y, Tanaka H et al (2017) Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int J Urol 24:511–517CrossRefPubMed Tanaka H, Fujii Y, Tanaka H et al (2017) Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int J Urol 24:511–517CrossRefPubMed
7.
go back to reference Romero FR, Rais-Bahrami S, Permpongkosol S et al (2006) Primary carcinoid tumors of the kidney. J Urol 176:2359–2366CrossRefPubMed Romero FR, Rais-Bahrami S, Permpongkosol S et al (2006) Primary carcinoid tumors of the kidney. J Urol 176:2359–2366CrossRefPubMed
9.
Metadata
Title
A young female case of primary renal carcinoid tumor mimicking fat-poor angiomyolipoma
Authors
Rie Kato
Hiroshi Fukushima
Masaki Kobayashi
Keizo Kawano
Shinji Morimoto
Publication date
01-10-2018
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 4/2018
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0341-2

Other articles of this Issue 4/2018

International Cancer Conference Journal 4/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine